Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer-Cell Activation and Subsequent Cell Death.
Journal: Cancer immunology research
Published: August 22, 2016
Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: March 19, 2015
Tumor-derived α-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 31, 2014
Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity.
Journal: Oncoimmunology
Published: June 28, 2012
Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities.
Journal: Oncoimmunology
Published: June 22, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026